Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,066.00
Bid: 12,064.00
Ask: 12,068.00
Change: -90.00 (-0.74%)
Spread: 4.00 (0.033%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS SUMMARY: THG Surges After Raising Revenue Guidance

Mon, 26th Oct 2020 10:35

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.

----------

FTSE 100 - WINNERS

----------

Pearson, up 3.6%. UBS upgraded the education publisher to Buy from Neutral.

----------

AstraZeneca, up 1.1%. The Anglo-Swedish drugmaker late Friday said clinical trials for its AZD1222 coronavirus vaccine, being developed alongside Oxford University, has been resumed around the world, as regulators in the US, UK, Brazil, South Africa and Japan confirmed that it is safe to do so. The US Food & Drug Administration authorised the restart of the trials in the US, as they resumed in other countries in recent weeks, following the review of all safety data from trials in other regions.

----------

FTSE 100 - LOSERS

----------

Royal Dutch Shell 'A', down 1.6%, Shell 'B', down 1.5%. The oil major was tracking spot oil prices lower, quoted at USD40.78 a barrel Monday morning, down sharply from USD42.25 late Friday. Warring factions in Libya signed a countrywide ceasefire on Friday brokered by the United Nations. The ceasefire is poised to lead to more Libyan oil supply to the market at a time when demand is weak. "The return of just one million barrels per day of extra production to the world market has sent oil into a tailspin. It highlights how fragile sentiment is to the supply/demand balance of oil in international markets. A double-dip recession in Europe will add to the demand concerns," said Oanda Markets analyst Jeffery Halley.

----------

FTSE 250 - WINNERS

----------

Synthomer, up 2.5%. JPMorgan raised the speciality chemicals firm to Overweight from Neutral.

----------

FTSE 250 - LOSERS

----------

Beazley, down 2.5%. Morgan Stanley downgraded the insurer to Equal Weight from Overweight.

----------

OTHER MAIN MARKET AND AIM - WINNERS

----------

THG Holdings, up 12%. The online retailing platform raised revenue guidance for 2020, following strong trading in the third quarter and continued momentum in the fourth quarter to date. THG said for the three months to the end of September, total revenue grew by 39% year-on-year to GBP378.1 million. The group reported growth across all businesses. The largest contributor was THG Beauty, which grew revenue by 45% to GBP157.5 million. However, it was the THG Lifestyle division which grew at the fastest percentage rate, with an 80% increase to GBP24.4 million. THG listed in London last month with a market capitalisation of GBP5.40 billion and at the time guided for annual revenue of GBP1.43 billion. As a result of the stronger quarterly performance, the group now expects revenue to be between GBP1.48 billion to GBP1.52 billion, reflecting a 30% to 33% increase from GBP1.14 billion the year before. "Longer-term excitement around the story is based on its Ingenuity platform which has been compared in some quarters to Ocado's online solution for global groceries firms. The Hut essentially picking up the IT and logistical requirements of the likes of PZ Cussons, Hotel Chocolat and Nestle," said AJ Bell's Russ Mould.

----------

OTHER MAIN MARKET AND AIM - LOSERS

----------

Advanced Oncotherapy, down 14% at 31.65 pence. The proton therapy provider said it intends to raise GBP7.7 million through a subscription, the proceeds of which will go towards strengthening the company's balance sheet and ensure its first LIGHT system is fully operational in 2021. The company said it will issue 25.7 million shares to clients of SI Capital and other investors at a price of 30p each. The issue price reflects a 18% discount to the company closing price on Friday at 37p. The newly issued shares will represent 7.7% of its enlarged issued share capital.

----------

Corcel, down 11% at 1.07 pence. The natural resource exploration and development company said it has raised GBP750,000 through the placing of 75 million shares at GBP0.01 per share. The placing price represents a 15% discount to Friday's closing price of 1.17 pence. London-based Corcel said the new cash will be used to exercise the option with Sinom Hong Kong Ltd to purchase the remaining AUD3.05 million - or GBP1.7 million - debt in Resource Mining Corp at a 65% discount, noting the the exercise of the option now entails the payment of AUD640,000 in cash and the issuance of 23.7 million shares to Sinom subsidiary Asia Pacific. The company added it will also use some of the proceeds to pursue additional opportunities in the battery metals space.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.